Submitted: 09 Mar 2017
Accepted: 29 May 2017
First published online: 30 Jun 2017
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Int J Basic Sci Med. 2017;2(2):71-72.
doi: 10.15171/ijbsm.2017.13
  Abstract View: 302
  PDF Download: 447
  Full Text View: 264


Toll-Like Receptors and Targeted Therapy in Diabetes Mellitus

Ali Bazi 1,2 *

1 Clinical Research Development Unit, Amir-Al-Momenin Hospital, Zabol University of Medical Sciences, Zabol, Iran
2 Pediatric Gastroenterology and Digestive Diseases Research Center, Zabol University of Medical Sciences, Zabol, Iran
*Correspondence to Ali Bazi, Tel/Fax: +985432232166 Email:


Role of immune system in diabetes mellitus (DM) has been emerged for a long time. Since then, the majority of focus has been toward the role of adaptive immunity, while little thoughts credited a role for innate immunity in this process. By the emerging role of innate immunity in DM pathogenesis, especially toll-like receptors (TLRs) superfamily, it is expected that therapeutic approaches target these components in future of pharmaceutical research in diabetes.
Please cite this article asfollows: Bazi A. Innateimmunity and targetedtherapy of diabetesmellitus. Int J Basic SciMed. 2017;2(2):71-72. doi:10.15171/ijbms.2017.13.
First name
Last name
Email address
Security code